Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies

  1. 1Department of Anesthesiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Key Laboratory of Anesthesiology (Shanghai Jiao Tong University), Ministry of Education, Shanghai 200127, China

Abstract

Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.

Related

  1. VEGF Signaling and Targeted Therapies in Cancer: Molecular Mechanisms, Clinical Applications, Resistance, and Cardiorenal Toxicities
    Abhishek Mishra, Md. Abdul Hye Khan, Ripa Jamal +2
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  2. Ubiquitination-Dependent Cyclin Regulation in Gastric Cancer and Emerging Targeted Therapies with Chinese Herbal Bioactive Compounds
    Sicheng Qian, Xinyi Zheng, Jiaqi Li +3
    CancersPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  3. Targeted Modulation of the Gut Microbiota in Obesity: From Dietary Interventions to Bacteriophage-Based Precision Therapies
    Sthefhany Nohemí Rodríguez-Arellano, Jean Pierre González-Gómez, José Roberto Aguirre-Sánchez +4
    NutrientsPeer-reviewedCC BY 4.0Molecular biology & gene regulationCrossref
  4. Gut microbiome and aging-related disorders: mechanistic insights and emerging microbiome-targeted therapies for healthy aging.
    Md Minarul Islam, Gabsik Yang, Ki Sung Kang
    Frontiers in nutritionPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
  5. Chimeric models of neurodegenerative diseases: from disease mechanisms to regenerative therapies.
    Laura Cáceres-Palomo, María Alfonso-Triguero, Arantzazu Belloso-Iguerategui +3
    Molecular neurodegeneration advancesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCPMC
BibTeX
@article{zhang2026autophagy,
  title = {{Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies}},
  author = {Shuyu Zhang and Ying Li and Xuefang Shen and Qionghui Zhan},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210274},
  url = {https://www.mdpi.com/1422-0067/27/22/10274},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Autophagy in Sepsis-Induced Immunothrombosis: Cell-Specific Mechanisms and Autophagy-Targeted Therapies
AU  - Shuyu Zhang
AU  - Ying Li
AU  - Xuefang Shen
AU  - Qionghui Zhan
PY  - 2026
DA  - 2026/11/16
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210274
UR  - https://www.mdpi.com/1422-0067/27/22/10274
AB  - Sepsis-induced immunothrombosis is a principal driver of organ failure. It arises when innate antimicrobial defenses escalate into systemic thromboinflammatory injury. Autophagy, a conserved lysosomal degradation pathway, dynamically calibrates the procoagulant potential of macrophages, neutrophils, platelets and endothelial cells. This study reviews how distinct autophagic processes, including macroautophagy, mitophagy, chaperone-mediated autophagy and LC3-associated phagocytosis and xenophagy, govern the procoagulant behavior of these cells during sepsis. We propose a conceptual biphasic framework that processes stages from early compensatory autophagy to late-phase autophagic flux collapse and relate this temporal evolution to the clinical spectrum of sepsis-induced coagulopathy. Finally, we evaluate autophagy-targeted therapeutic strategies, including classic regulators, cell-specific nanodelivery systems and emerging gene-/RNA-targeted approaches, while emphasizing that most evidence remains mechanistic or preclinical. By integrating cellular heterogeneity with temporal dynamics, this review provides a mechanistic rationale for cell-targeted approaches to sepsis-induced coagulopathy.
SN  - 1422-0067
ER  -